Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmitalia-Carlo Erba
Milan, Lombardy, Italy
- Ownership
- Private
- Development stage
- Other
01
Overview
Farmitalia-Carlo Erba was a prominent Italian pharmaceutical company formed in 1978 through the merger of Farmitalia and Carlo Erba. The company achieved global recognition for its pioneering research in oncology, particularly for the discovery and development of the anthracycline class of chemotherapy drugs, including doxorubicin (Adriamycin) and epirubicin. Beyond its oncology leadership, the firm maintained a diverse portfolio in infectious diseases, cardiovascular health, and endocrinology. In 1993, the company was acquired by the Swedish firm Pharmacia, and through subsequent mergers, its legacy and products eventually became part of Pfizer. Its contributions to cancer treatment remain foundational to modern oncology.
- Therapeutic areas
- OncologyEndocrinology
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on Farmitalia-Carlo Erba.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Farmitalia-Carlo Erba.